PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	34-41	thymoma viral proto-oncogene 1	Mus musculus	74-77	
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	34-41	thymoma viral proto-oncogene 1	Mus musculus	104-107	
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	34-41	thymoma viral proto-oncogene 1	Mus musculus	285-288	
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	156-163	thymoma viral proto-oncogene 1	Mus musculus	74-77	
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	156-163	thymoma viral proto-oncogene 1	Mus musculus	104-107	
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	156-163	thymoma viral proto-oncogene 1	Mus musculus	285-288	
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	274-281	thymoma viral proto-oncogene 1	Mus musculus	74-77	
35370703-8	2022	Mechanistic studies revealed that KRIBB11 incubation up-regulated phospho-Akt in cultured microglia and Akt inhibition blocked the pro-elongation effect of KRIBB11 on microglial process in cultured conditions and in vivo conditions, suggesting that the regulatory effect of KRIBB11 is Akt-dependent.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	274-281	thymoma viral proto-oncogene 1	Mus musculus	104-107	
35370703-9	2022	Akt inhibition was also found to abrogate the preventive effect of KRIBB11 on LPS-induced inflammatory responses in primary cultured microglia and prefrontal cortexes as well as LPS-induced depression-like behaviors in mice.	N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine	67-74	thymoma viral proto-oncogene 1	Mus musculus	0-3